Liu, Shengjie
Wang, Yuanmei
Yang, Hanlin
Tan, Jun
Zhang, Jingkaiwen
Funding for this research was provided by:
Guizhou Medical University (YJ19017, HY2020)
National Natural Science Foundation of China (82171423, 82060211)
Anyu Biotechnology (Hangzhou) Co., Ltd.., Hangzhou (06202010204)
Guizhou Provincial Science and Technology Department (grant No.ZK[2022]270, grant No.ZK[2021]459)
Article History
Received: 17 January 2024
Accepted: 20 March 2024
First Online: 5 April 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki. The animal study protocol was approved by the Ethics Committee of Guizhou University (protocol code: EAE-GZU-2022-E035, approval date: 3 November 2022) for studies involving animals. Title of the approved project: Experimental study of mesenchymal stem cell-derived mitochondrial transplantation combined with pyrriloquinoline quinone for premature ovarian insufficiency after chemotherapy.
: Not applicable.
: The authors declare no conflict of interest.